Brooke Eby was just 33 when she was diagnosed in 2022 with amyotrophic lateral sclerosis—ALS, otherwise known as Lou Gehrig's ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that preclinical research exploring key mechanisms underlying amyotrophic lateral sclerosis (ALS) pathology will be presented at the 2025 ...

Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) ...

Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA breakthrough therapy designation, underway in post-bariatric hypoglycemia (PBH); completion ...

As we move deeper into may, the East Texas harvest season will begin to show, whether its a bumper crop or a ‘break even’ season.

Jeffrey Lee Sharp, 62, faced trial on Monday in Judge R. Scott McKee’s courtroom and was convicted by a jury on Tuesday despite pleading not guilty.

Smith's synthetic voice was created by analyzing old recordings made before his illness, allowing him to regain a voice for his thoughts and communicate in a voice similar to his own.

Brad Smith showed the internet how he edits video with nothing but thought, on the YouTube clip he posted last week. The ...

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

STATEN ISLAND, N.Y. — Robert Moffit, a lifelong Staten Island resident who became an advocate for New York’s Medical Aid in ...

A special art tour program at the Virginia Museum of Fine Arts is bringing light and connection to people living with ALS and ...

Clene (NASDAQ: CLNN) announced first quarter 2025 financial results and progress on its CNM-Au8 program for ALS and MS. The company is preparing for ...